Alsakali Equity AB

Filings at 1 company/Chief executive officer · Newbury Pharmaceuticals AB

5 of 21 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 21. Reading the whole list, and the full company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market purchases they reported, and over which period — and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The 5 most recent of 21 visible filings, newest first.

Newbury Pharmaceuticals AB Chief executive officer
41,116 SEKOpen-market buy
TradedNov 18, 2025FiledNov 18, 2025
Newbury Pharmaceuticals AB Chief executive officer
94,318 SEKOpen-market buy
TradedNov 17, 2025FiledNov 17, 2025
Newbury Pharmaceuticals AB Chief executive officer
38,172 SEKOpen-market buy
TradedNov 12, 2025FiledNov 12, 2025
Newbury Pharmaceuticals AB Chair of the board
612,500 sharesAdministrative
TradedApr 8, 2024FiledApr 10, 2024
Newbury Pharmaceuticals AB Chair of the board
612,500 sharesAdministrative
TradedMar 4, 2024FiledMar 4, 2024